Rekah Pharmaceutical Industry Ltd (REKA) — Net Asset Quality Index
Rekah Pharmaceutical Industry Ltd (REKA) has a Net Asset Quality Index of 34.0% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA423.68 Million minus total liabilities of ILA279.47 Million yields net assets of ILA144.21 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of Rekah Pharmaceutical Industry Ltd to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Rekah Pharmaceutical Industry Ltd Net Asset Quality Index Over Time (2004–2025)
This chart shows how Rekah Pharmaceutical Industry Ltd's Net Asset Quality Index has evolved across 22 annual periods from 2004 to 2025. As of December 2025, the index stands at 34.0%, representing net assets of ILA144.21 Million against total assets of ILA423.68 Million ILA. See working capital position of Rekah Pharmaceutical Industry Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Rekah Pharmaceutical Industry Ltd (2004–2025)
The table below presents the year-by-year Net Asset Quality Index for Rekah Pharmaceutical Industry Ltd from 2004 to 2025, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Rekah Pharmaceutical Industry Ltd market cap and net worth.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.0% | ILA144.21 Million | ILA423.68 Million | ILA279.47 Million | ▼ -2.2 pp |
| 2024 | 36.2% | ILA161.98 Million | ILA447.22 Million | ILA285.24 Million | ▲ +4.1 pp |
| 2023 | 32.1% | ILA155.59 Million | ILA484.72 Million | ILA329.14 Million | ▼ -4.0 pp |
| 2022 | 36.1% | ILA162.08 Million | ILA448.42 Million | ILA286.34 Million | ▼ -3.4 pp |
| 2021 | 39.6% | ILA173.06 Million | ILA437.09 Million | ILA264.02 Million | ▲ +0.1 pp |
| 2020 | 39.5% | ILA165.59 Million | ILA419.69 Million | ILA254.10 Million | ▼ -2.8 pp |
| 2019 | 42.3% | ILA155.22 Million | ILA367.11 Million | ILA211.89 Million | ▼ -7.9 pp |
| 2018 | 50.2% | ILA150.66 Million | ILA300.28 Million | ILA149.62 Million | ▲ +1.1 pp |
| 2017 | 49.0% | ILA144.62 Million | ILA294.95 Million | ILA150.33 Million | ▲ +16.2 pp |
| 2016 | 32.8% | ILA105.86 Million | ILA322.72 Million | ILA216.86 Million | ▼ -5.4 pp |
| 2015 | 38.2% | ILA123.66 Million | ILA323.82 Million | ILA200.17 Million | ▲ +13.3 pp |
| 2014 | 24.8% | ILA77.06 Million | ILA310.11 Million | ILA233.05 Million | ▼ -1.4 pp |
| 2013 | 26.2% | ILA79.51 Million | ILA303.16 Million | ILA223.65 Million | ▲ +2.4 pp |
| 2012 | 23.9% | ILA71.17 Million | ILA298.07 Million | ILA226.90 Million | ▲ +1.6 pp |
| 2011 | 22.3% | ILA64.00 Million | ILA286.99 Million | ILA222.98 Million | ▲ +0.2 pp |
| 2010 | 22.1% | ILA63.78 Million | ILA287.97 Million | ILA224.18 Million | ▼ -0.9 pp |
| 2009 | 23.0% | ILA64.15 Million | ILA278.40 Million | ILA214.25 Million | ▲ +2.9 pp |
| 2008 | 20.2% | ILA58.62 Million | ILA290.50 Million | ILA231.87 Million | ▼ -2.1 pp |
| 2007 | 22.3% | ILA67.10 Million | ILA300.96 Million | ILA233.86 Million | ▲ +1.5 pp |
| 2006 | 20.8% | ILA61.54 Million | ILA296.53 Million | ILA234.99 Million | ▼ -1.3 pp |
| 2005 | 22.0% | ILA58.85 Million | ILA267.00 Million | ILA208.15 Million | ▼ -2.1 pp |
| 2004 | 24.2% | ILA48.86 Million | ILA202.04 Million | ILA153.18 Million | — |